TCOV
AGN

Trust Company of Vermont’s Allergan plc AGN Stock Holding History

Trust Company of Vermont’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10
Closed -$2K – 904
2020
Q1 		$2K Buy
+10
New +$1.88K ﹤0.01% 832
2019
Q4 		– Sell
-15
Closed -$3K – 982
2019
Q3 		$3K Buy
+15
New +$2.44K ﹤0.01% 917
2019
Q2 		– Sell
-200
Closed -$29K – 1060
2019
Q1 		$29K Sell
200
-90
-31% -$13K ﹤0.01% 553
2018
Q4 		$39K Sell
290
-205
-41% -$33.6K ﹤0.01% 501
2018
Q3 		$94K Sell
495
-80
-14% -$14.7K 0.01% 424
2018
Q2 		$96K Sell
575
-147
-20% -$23.6K 0.01% 415
2018
Q1 		$121K Sell
722
-14
-2% -$2.35K 0.01% 375
2017
Q4 		$120K Sell
736
-2,616
-78% -$469K 0.01% 381
2017
Q3 		$687K Buy
3,352
+80
+2% +$18.6K 0.07% 196
2017
Q2 		$796K Buy
3,272
+397
+14% +$93.3K 0.08% 181
2017
Q1 		$687K Buy
2,875
+1,109
+63% +$258K 0.07% 188
2016
Q4 		$370K Buy
1,766
+1,128
+177% +$234K 0.04% 236
2016
Q3 		$147K Buy
638
+93
+17% +$22.7K 0.02% 306
2016
Q2 		$126K Buy
545
+89
+20% +$20.5K 0.02% 296
2016
Q1 		$123K Sell
456
-12
-3% -$3.44K 0.02% 298
2015
Q4 		$147K Buy
468
+25
+6% +$7.44K 0.02% 272
2015
Q3 		$121K Buy
443
+41
+10% +$12.6K 0.02% 284
2015
Q2 		$122K Sell
402
-10
-2% -$2.98K 0.02% 289
2015
Q1 		$123K Buy
412
+90
+28% +$25.7K 0.02% 284
2014
Q4 		$83K Sell
322
-23
-7% -$5.75K 0.01% 332
2014
Q3 		$83K Buy
345
+88
+34% +$19.7K 0.01% 328
2014
Q2 		$57K Buy
257
+25
+11% +$5.18K 0.01% 360
2014
Q1 		$48K Hold
232
– – 0.01% 376
2013
Q4 		$39K Buy
232
+32
+16% +$5K 0.01% 392
2013
Q3 		$29K Buy
+200
New +$26.6K 0.01% 418

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Trust Company of Vermont's AGN Position: Q2 2020 in Review

Trust Company of Vermont sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 10 shares — an estimated $2K sold.

Trust Company of Vermont first reported a position in AGN in Q3 2013 and held it in 25 quarters. The position peaked at $796K in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Trust Company of Vermont reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Trust Company of Vermont sold 10 Allergan plc shares in Q2 2020, an estimated $2K.
  • Trust Company of Vermont first reported a position in Allergan plc in Q3 2013 and held it in 25 quarters.
  • Trust Company of Vermont's Allergan plc position peaked at $796K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Trust Company of Vermont's 13F filing for Q2 2020, filed 17 Jul 2020.